Jennifer Pritzker Sells 4,000 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 4,000 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $25.75, for a total value of $103,000.00. Following the sale, the insider directly owned 6,897,764 shares in the company, valued at $177,617,423. This trade represents a 0.06% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Down 3.0%

Shares of NASDAQ KIDS opened at $23.32 on Friday. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The company has a market cap of $608.89 million, a P/E ratio of -13.88 and a beta of 0.98. OrthoPediatrics Corp. has a 52 week low of $14.42 and a 52 week high of $26.74. The business has a 50-day simple moving average of $21.32 and a two-hundred day simple moving average of $18.62.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The firm had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. Research analysts anticipate that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors and hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System grew its stake in OrthoPediatrics by 397.1% in the 2nd quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock worth $87,000 after buying an additional 3,637 shares in the last quarter. Nantahala Capital Management LLC bought a new position in shares of OrthoPediatrics in the 2nd quarter worth $4,636,002,000. Grandeur Peak Global Advisors LLC purchased a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $954,000. Bank of America Corp DE purchased a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $268,000. Finally, AWM Investment Company Inc. bought a new stake in shares of OrthoPediatrics during the 2nd quarter worth $4,537,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting OrthoPediatrics

Here are the key news stories impacting OrthoPediatrics this week:

• Positive Sentiment: OrthoPediatrics completed the full U.S. commercial launch of its 3P™ Pediatric Plating Platform® Hip System after more than 350 successful implantations during its limited release. The system expands the company’s pediatric trauma and deformity portfolio and could create a long-term revenue and market-share opportunity, though management did not provide specific financial guidance. 3P Pediatric Plating Platform Hip System launch
• Positive Sentiment: Analyst sentiment remains favorable. Piper Sandler raised its target to $25, Needham lifted its target to $35, and BTIG increased its target to $29, while maintaining positive ratings. MarketBeat data shows a “Moderate Buy” consensus with an average target of $26.44.
• Positive Sentiment: Recent quarterly results exceeded expectations: OrthoPediatrics reported a loss of $0.26 per share versus the estimated loss of $0.30, while revenue of $70.51 million surpassed the $68.21 million consensus estimate. BlackRock and other institutional investors also recently initiated or expanded positions.
• Neutral Sentiment: Reported short interest was listed at zero shares, but an invalid change figure makes the data unreliable and limits its usefulness for assessing short-selling pressure.
• Negative Sentiment: Director David R. Pelizzon and major shareholders associated with Squadron Capital and Jennifer N. Pritzker sold a combined 38,300 shares for approximately $943,302 across August 24–26, at prices ranging from $24.28 to $25.75. The sales reduced their position by roughly 0.56%, leaving ownership of about 6.86 million shares. While modest relative to their remaining stake, repeated insider selling may weigh on investor sentiment, particularly with the stock near its 52-week high. SEC insider transaction filing

Wall Street Analysts Forecast Growth

KIDS has been the topic of several recent analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a report on Wednesday, August 5th. Needham & Company LLC increased their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, BTIG Research lifted their price objective on OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Nine equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and an average target price of $26.44.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.